COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,620 Articles (22,913 medRxiv, 8,707 bioRxiv)

Most recent first Previous |  Page 1622: Articles 16211-16220  | Next

Estimation of local time-varying reproduction numbers in noisy surveillance data
Li, W., Bulekova, K., Gregor, B., White, L. F., Kolaczyk, E. D.
10.1101/2021.04.23.21255958 — Posted: 2021-04-26
Indirect Effects of COVID-19 on Maternal, Neonatal, Child, Sexual and Reproductive Health Services in Kampala, Uganda
Burt, J. F., Ouma, J., Amone, A., Aol, L., Sekikubo, M., Nakimuli, A., Nakabembe, E., Mboizi, R., Musoke, P., Kyohere, M., Namara, E., Khalil, A., Le Doare, K.
10.1101/2021.04.23.21255940 — Posted: 2021-04-26
Tocilizumab and mortality in hospitalised patients with covid-19. A systematic review comparing randomised trials with observational studies
Podmore, B., Qizilbash, N., Lacetera, A., Ubillos, I., Andresen, K., Roncero Martin, A., Majuelos-Melguizo, J., Cunado Moral, A., Hinojosa Campos, M., Aronson, J. K., Pocock, S.
10.1101/2021.04.23.21255815 — Posted: 2021-04-26
Role of non-aerosols activities in the transmission of SARS-Cov-2 infection among health care workers.
Paris, C., Tadie, E., Heslan, C., Gary-Bobo, P., Oumary, S., Sitruck, A., Wild, P., Tattevin, P., Thibault, V., Garlantezec, R.
10.1101/2021.04.22.21255922 — Posted: 2021-04-26
Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses
Beaudoin, C. A., Jamasb, A. R., Alsulami, A., Copoiu, L., van Tonder, A. J., Hala, S., Bannerman, B. P., Thomas, S. E., Vedithi, S. C., Torres, P. H. M., Blundell, T. L.
10.1101/2021.04.23.441187 — Posted: 2021-04-26
Household transmission of SARS-CoV-2 from humans to dogs in Washington and Idaho: burden and risk factors
Meisner, J., Baszler, T., Kuehl, K., Ramirez, V., Baines, A., Frisbie, L., Lofgren, E., DeAvila, D., Wolking, R., Bradway, D., Rabinowitz, P.
10.1101/2021.04.24.440952 — Posted: 2021-04-26
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
Jette, C. A., Cohen, A. A., Gnanapragasam, P. N. P., Muecksch, F., Lee, Y. E., Huey-Tubman, K. E., Schmidt, F., Hatziioannou, T., Bieniasz, P. D., Nussenzweig, M. C., West, A. P., Keeffe, J. R., Bjorkman, P., Barnes, C. O.
10.1101/2021.04.23.441195 — Posted: 2021-04-26
A synthetic peptide CTL vaccine targeting nucleocapsid confers protection from SARS-CoV-2 challenge in rhesus macaques
Harris, P., Brasel, T., Massey, C., Herst, C., Burkholz, S., Lloyd, P., Blankenberg, T., Bey, T., Carback, R., Hodge, T., Ciotlos, S., Wang, L., Comer, J. E., Rubsamen, R. M.
10.1101/2021.04.24.441228 — Posted: 2021-04-26
Autoantibodies against Progranulin and IL-1 receptor antagonist in critically ill COVID-19
Thurner, L., Fadle, N., Bewarder, M., Kos, I., Regitz, E., Cetin, O., Thurner, B., Fischer, Y., Rixecker, T., Preuss, K.-D., Schormann, C., Neumann, F., Hartmann, S., Bock, T., Kaddu-Mulindwa, D., Bette, B., Bittenbring, J. T., Christofyllakis, K., Bick, A., Lesan, V., Abdi, Z., Mang, S., Becker, A., Metz, C., Seiler, F., Lehmann, J., Agne, P., Adams, T., Link, A., Werner, C., Thiel-Bodenstaff, A., Reichert, M., Danziger, G., Papan, C., Pilch, J., Pfuhl, T., Wuchter, P., Herr, C., Lohse, S., Schrezenmeier, H., Boehm, M., Langer, F., Gaebelein, G., Friesenhahn-Ochs, B., Bals, R., Lammert, F., Koerper, S., Rissland, J., Lensch, C., Stilgenbauer, S., Becker, S. L., Smola, S., Krawczyk, M., Lepper, P.
10.1101/2021.04.23.441188 — Posted: 2021-04-26
Binding mechanism of neutralizing Nanobodies targeting SARS-CoV-2 Spike Glycoprotein
Golcuk, M., Hacisuleyman, A., Erman, B., Yildiz, A., Gur, M.
10.1101/2021.04.23.441186 — Posted: 2021-04-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).